Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler–Najjar syndrome G Bortolussi, L Zentillin, J Vaníkova, L Bockor, C Bellarosa, A Mancarella, ... Human gene therapy 25 (9), 844-855, 2014 | 89 | 2014 |
The biological effects of bilirubin photoisomers J Jasprova, M Dal Ben, E Vianello, I Goncharova, M Urbanova, ... PLoS One 11 (2), e0148126, 2016 | 35 | 2016 |
Alterations in the cell cycle in the cerebellum of hyperbilirubinemic Gunn rat: a possible link with apoptosis? MC Robert, G Furlan, N Rosso, SE Gambaro, F Apitsionak, E Vianello, ... PLoS One 8 (11), e79073, 2013 | 30 | 2013 |
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat E Vianello, S Zampieri, T Marcuzzo, F Tordini, C Bottin, A Dardis, ... Scientific reports 8 (1), 13690, 2018 | 20 | 2018 |
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study E Vianello, P Gonzalez-Dias, S van Veen, CG Engele, E Quinten, ... The Lancet Microbe 3 (2), e113-e123, 2022 | 6 | 2022 |
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment CLR van Doorn, C Eckold, K Ronacher, R Ruslami, S van Veen, JS Lee, ... EBioMedicine 82, 2022 | 5 | 2022 |
Differences in inflammatory pathways between Dutch South Asians vs Dutch Europids with type 2 diabetes ME Straat, B Martinez-Tellez, HJ Van Eyk, MB Bizino, S Van Veen, ... The Journal of Clinical Endocrinology & Metabolism 108 (4), 931-940, 2023 | 3 | 2023 |
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP E Vianello, J Persson, B Andersson, S van Veen, TL Dias, F Santoro, ... iScience 26 (12), 2023 | 1 | 2023 |
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts PC Gonzalez Dias Carvalho, T Dominguez Crespo Hirata, LY Mano Alves, ... Frontiers in Immunology 14, 1259197, 2023 | 1 | 2023 |
Whole blood RNA signatures in tuberculosis patients receiving H56: IC31 vaccine as adjunctive therapy N Alonso-Rodríguez, E Vianello, S Van Veen, S Jenum, K Tonby, ... Frontiers in Immunology 15, 1350593, 2024 | | 2024 |
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability A Huttner, ST Agnandji, O Engler, JW Hooper, S Kwilas, K Ricks, ... Clinical Microbiology and Infection 29 (12), 1587-1594, 2023 | | 2023 |
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity C Eckold, CLR van Doorn, R Ruslami, K Ronacher, AL Riza, S van Veen, ... Clinical and Translational Medicine 13 (9), e1375, 2023 | | 2023 |
In vivo evaluation of biomolecular mechanisms of bilirubin toxicity and pre-clinical therapies. E Vianello Università degli Studi di Trieste, 2017 | | 2017 |
Life-long liver-specific AAV-mediated gene therapy in a Crigler-Najjar mouse model G Bortolussi, L Zentilin, J Vanıkova, E Vianello, A Mancarella, L Bočkor, ... The European Society for Gene and Cell Therapy and the Spanish Society for …, 2013 | | 2013 |
Antibody responses to rVSV-ZEBOV vaccination for Ebola virus disease across doses and continents: five-year durability | | |